OncBioMune Pharmaceuticals, Inc (34)

Browse by Contract Category

Business Finance (31)
Human Resources (3)

Contracts

Securities Purchase Agreement, dated September 16, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investor (Filed With SEC on September 22, 2020)
Consulting Agreement between OncBioMune Pharmaceuticals, Inc. and Andrew Kucharchuk dated June 5, 2020 (Filed With SEC on June 11, 2020)
Separation Agreement and General Release of Claims between OncBioMune Pharmaceuticals, Inc. and Andrew Kucharchuk dated June 5, 2020 (Filed With SEC on June 11, 2020)
Securities Purchase Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. Cavalry Fund I LP and Lincoln Park Capital Fund, LLC (Filed With SEC on June 11, 2020)
Exchange Agreement, dated June 5, 2020, by and between OncBioMune Pharmaceuticals, Inc. and Jonathan F. Head, Ph.D (Filed With SEC on June 11, 2020)
Exchange Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investors named therein (Filed With SEC on June 11, 2020)
Exchange Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investors named therein (Filed With SEC on June 11, 2020)
Exchange Warrant, dated June 5, 2020 (Filed With SEC on June 11, 2020)
Form of Warrant (Filed With SEC on June 11, 2020)
Asset Purchase Agreement, dated May 12, 2020, between OncBioMune Pharmaceuticals, Inc. and Avant Diagnostics, Inc (Filed With SEC on May 13, 2020)
Description of Capital Stock (Filed With SEC on March 25, 2020)
Securities Purchase Agreement dated September 25, 2019 (Filed With SEC on November 19, 2019)
Warrant dated September 25, 2019 (Filed With SEC on November 19, 2019)
Note dated September 25, 2019 (Filed With SEC on November 19, 2019)
Form of Warrant (Filed With SEC on August 6, 2019)
Securities Purchase Agreement (Filed With SEC on August 6, 2019)
Form of Note (Filed With SEC on August 6, 2019)
Form of Warrant (Filed With SEC on July 18, 2019)
Form of Note (Filed With SEC on July 18, 2019)
Form of Securities Purchase Agreement (Filed With SEC on July 18, 2019)
Form of Securities Purchase Agreement (Filed With SEC on May 2, 2019)
Form of Warrant (Filed With SEC on May 2, 2019)
Form of Note (Filed With SEC on May 2, 2019)
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP, dated March 25, 2019 (Filed With SEC on April 1, 2019)
Common Stock Purchase Warrant issued March 25, 2019 to Cavalry Fund I LP (Filed With SEC on April 1, 2019)
Senior Convertible Note issued March 25, 2019 to Cavalry Fund I LP (Filed With SEC on April 1, 2019)
Employment Agreement effective as of December 26, 2018 between OncBioMune Pharmaceuticals, Inc. and Brian Barnett, MD (Filed With SEC on April 1, 2019)
Shareholders Agreement among OncBioMune Pharmaceuticals, Inc., Jonathan F. Head, Ph.D., Andrew A. Kucharchuk, Manuel Cosme Odabachian and Carlos Fernando Alaman Volnie dated March... (Filed With SEC on February 21, 2019)
Irrevocable Trust Agreement Number F/2868 entered into among Manuel Cosme Odabachian, Carlos Fernando Alaman Volnie and OncBioMune Pharmaceuticals, Inc. as beneficiaries and Banco... (Filed With SEC on February 21, 2019)
Contribution Agreement to the Property of Trust F/2868 entered into among Manuel Cosme Odabachian, Carlos Fernando Alaman Volnie and OncBioMune Pharmaceuticals, Inc. dated March... (Filed With SEC on February 21, 2019)
Convertible Redeemable Note, dated as of January 18, 2019 (Filed With SEC on February 4, 2019)
Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and Cerberus Finance Group Ltd (Filed With SEC on February 4, 2019)
Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and LG Capital Funding LLC (Filed With SEC on January 29, 2019)
Convertible Redeemable Note, dated as of January 18, 2019 (Filed With SEC on January 29, 2019)